SCHEMBL25211797

SCHEMBL25211797

N#C[C@@]1(c2ccc3c(NC4CC4)ncnn23)O[C@H](COCc2ccccc2)[C@@H](OCc2ccccc2)[C@H]1OCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TMPRSS2 O15393 1/20 0.37
▸ MAPKAPK2 P49137 2/20 0.31
▸ HTR1A P08908 1/20 0.31
▸ BCHE P06276 2/20 0.31
▸ ACHE P22303 1/20 0.31
▸ IRAK4 Q9NWZ3 1/20 0.30
▸ CTSL P07711 1/20 0.30
▸ CTSB P07858 1/20 0.30
▸ CTSK P43235 1/20 0.30
▸ PTPN1 P18031 2/20 0.30
▸ CDC25B P30305 2/20 0.30
▸ CCNK O75909 1/20 0.30
▸ CCNA2 P20248 1/20 0.30
▸ CDK2 P24941 1/20 0.30
▸ CDK12 Q9NYV4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15084421 0.90 TMPRSS2 (0.39) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL25273419 0.86 TMPRSS2 (0.36) TMPRSS2HTR1ABCHEPTPN1CDC25B
SCHEMBL29727834 0.85 PDE2A (0.35) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL20477154 0.85 PDE2A (0.35) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL27086511 0.85 PDE2A (0.35) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL12243178 0.85 PDE2A (0.35) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL17712276 0.85 PDE2A (0.35) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL25259971 0.85 BCHE (0.36) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL20553048 0.85 PDE2A (0.35) TMPRSS2HTR1ABCHEACHEPTPN1
SCHEMBL28408184 0.85 HTR1A (0.33) TMPRSS2HTR1ABCHEACHEPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102472-A1 ANTIVIRAL PRODRUGS AND FORMULATIONS THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2023-06-08 — — WO disclosed
Send feedback